Ticagrelor-Induced complete heart block: A rare entity

Wagle Varun Anand; Isha Khadke; R. Padmakumar; M. Sudhakar Rao; Bharti Chogtu

doi:10.4103/jpp.JPP_121_19

Ticagrelor-Induced complete heart block: A rare entity

Wagle Varun Anand
, Isha Khadke^*
, R. Padmakumar
, M. Sudhakar Rao
, Bharti Chogtu

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

Ticagrelor, a purinergic P2Y12 receptor blocker, is a potent platelet antagonist and an important component in the treatment for acute coronary syndromes identified to have a potential risk to cause bradyarrhythmias. Here, we report the case of a diabetic patient of unstable angina with left bundle branch block who was prescribed ticagrelor post angioplasty. Electrocardiogram (ECG) revealed a complete heart block after about 1 week. Ticagrelor was stopped and replaced by clopidogrel. The patient became asymptomatic and ECG showed baseline rhythm after 1 week of stoppage of ticagrelor.

Original language	English
Pages (from-to)	75-77
Number of pages	3
Journal	Journal of Pharmacology and Pharmacotherapeutics
Volume	11
Issue number	2
DOIs	https://doi.org/10.4103/jpp.JPP_121_19
Publication status	Published - 01-04-2020

All Science Journal Classification (ASJC) codes

Pharmacology
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4103/jpp.JPP_121_19

Cite this

@article{a5a84b0b88a64852a2d2fe685a74ae11,

title = "Ticagrelor-Induced complete heart block: A rare entity",

abstract = "Ticagrelor, a purinergic P2Y12 receptor blocker, is a potent platelet antagonist and an important component in the treatment for acute coronary syndromes identified to have a potential risk to cause bradyarrhythmias. Here, we report the case of a diabetic patient of unstable angina with left bundle branch block who was prescribed ticagrelor post angioplasty. Electrocardiogram (ECG) revealed a complete heart block after about 1 week. Ticagrelor was stopped and replaced by clopidogrel. The patient became asymptomatic and ECG showed baseline rhythm after 1 week of stoppage of ticagrelor. ",

author = "Anand, \{Wagle Varun\} and Isha Khadke and R. Padmakumar and \{Sudhakar Rao\}, M. and Bharti Chogtu",

note = "Publisher Copyright: {\textcopyright} 2020 Journal of Pharmacology and Pharmacotherapeutics | Published by Wolters Kluwer - Medknow. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",

year = "2020",

month = apr,

day = "1",

doi = "10.4103/jpp.JPP\_121\_19",

language = "English",

volume = "11",

pages = "75--77",

journal = "Journal of Pharmacology and Pharmacotherapeutics",

issn = "0976-500X",

publisher = "Sage Publications India Pvt. Ltd",

number = "2",

}

TY - JOUR

T1 - Ticagrelor-Induced complete heart block

T2 - A rare entity

AU - Anand, Wagle Varun

AU - Khadke, Isha

AU - Padmakumar, R.

AU - Sudhakar Rao, M.

AU - Chogtu, Bharti

PY - 2020/4/1

Y1 - 2020/4/1

N2 - Ticagrelor, a purinergic P2Y12 receptor blocker, is a potent platelet antagonist and an important component in the treatment for acute coronary syndromes identified to have a potential risk to cause bradyarrhythmias. Here, we report the case of a diabetic patient of unstable angina with left bundle branch block who was prescribed ticagrelor post angioplasty. Electrocardiogram (ECG) revealed a complete heart block after about 1 week. Ticagrelor was stopped and replaced by clopidogrel. The patient became asymptomatic and ECG showed baseline rhythm after 1 week of stoppage of ticagrelor.

AB - Ticagrelor, a purinergic P2Y12 receptor blocker, is a potent platelet antagonist and an important component in the treatment for acute coronary syndromes identified to have a potential risk to cause bradyarrhythmias. Here, we report the case of a diabetic patient of unstable angina with left bundle branch block who was prescribed ticagrelor post angioplasty. Electrocardiogram (ECG) revealed a complete heart block after about 1 week. Ticagrelor was stopped and replaced by clopidogrel. The patient became asymptomatic and ECG showed baseline rhythm after 1 week of stoppage of ticagrelor.

UR - https://www.scopus.com/pages/publications/85095746600

UR - https://www.scopus.com/pages/publications/85095746600#tab=citedBy

U2 - 10.4103/jpp.JPP_121_19

DO - 10.4103/jpp.JPP_121_19

M3 - Article

AN - SCOPUS:85095746600

SN - 0976-500X

VL - 11

SP - 75

EP - 77

JO - Journal of Pharmacology and Pharmacotherapeutics

JF - Journal of Pharmacology and Pharmacotherapeutics

IS - 2

ER -

Ticagrelor-Induced complete heart block: A rare entity

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this